Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SFXN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NFIA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIPRL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MLXIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C9orf66 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CCDC171 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFR1OP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
OR7E37P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AAMDC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf122 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF876P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP1B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on